Press Releases
Search
-
01 Mar 2017
bioMérieux – 2016 Financial Results
Remarkable growth in sales in 2016, up 9.6% at constant exchange rates and scope of consolidation: €2,103 million in sales Up 7.1% as reported Contributive operating income before non-recurring items:...
-
24 Feb 2017
bioMérieux’s VIDAS® B•R•A•H•M•S PCT™ becomes the first FDA-cleared procalcitonin assay as an aid for antibiotic stewardship in respiratory infections and sepsis
bioMérieux, a world leader in the field of in vitro diagnostics, has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for the expanded use of VIDAS® B•R•A•H•M•S PCT™, an auto...
-
24 Feb 2017
bioMérieux Sells its Hemostasis Line of Business
Marcy l'Etoile - 05/25/2006. bioMérieux, a global leader in the field of in vitro diagnostics, today announced that it has signed an agreement to sell its hemostasis range of products to Trinity Biote...
-
19 Jan 2017
bioMérieux and Banyan Biomarkers Partner to Develop, Validate and Market Blood-Based Biomarkers for Traumatic Brain Injury
bioMérieux, a world leader in the field of in vitro diagnostics and Banyan Biomarkers, an innovative biomarkers company developing blood tests capable of diagnosing traumatic brain injuries (TBI), ann...
-
19 Jan 2017
bioMérieux – Information financière du 4e trimestre 2016
Croissance remarquable des ventes en 2016, +9,6 % à taux de change et périmètre constants, alimentée par toutes les régions et par toutes les gammes stratégiques : Chiffre d’affaires : 2 103 millions ...
-
19 Jan 2017
bioMérieux – Fourth-Quarter 2016 Business Review
Remarkable growth in sales in 2016, up 9.6% like-for-like, lifted by all regions and all strategic lines: €2,103 million in sales Up 7.1% as reported Strong contribution from the Americas region to Gr...